Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Coronavirus pandemic update

23 Mar 2020 07:34

RNS Number : 1674H
Compagnie de Saint-Gobain
23 March 2020
 

PRESS RELEASE

 

 

March 23, 2020, at 8:00 am

 

 

SAINT-GOBAIN PUTS IN PLACE NECESSARY MEASURES TO ADAPT

TO THE CORONAVIRUS PANDEMIC

 

 

Saint-Gobain's businesses are disrupted in the countries impacted by the coronavirus, with very different situations from one country to another.

 

Since the start of the health crisis in China, the Group has taken the necessary measures to ensure the health of its employees, customers, suppliers and other stakeholders. It is cooperating with the authorities in each country where it is present.

 

In terms of its business activity, Saint-Gobain is quickly adapting to the evolution in demand, aiming for operational continuity, depending on the health situation and on government decisions in each country, whilst reducing costs (reduction of teams, partial unemployment or stoppages) and prioritizing the health of its stakeholders:

 

- In our distribution activities, which mostly serve trade professionals rather than the general public, the Group has adjusted its service offering to customers over the last few days, with new procedures in terms of orders for collection, delivery and via online and telephone orders; in particular, certain brands in France that were closed for a few days have progressively recommenced business;

- In our manufacturing activities, sites have made the necessary adjustments given the impacts of the crisis on the value chain, in particular in the automotive market. The operation of our factories is continuously adapted as the situation evolves, in a very flexible manner within the new organization. In this respect, all of our Chinese factories have restarted operations, following the rapid improvement in demand.

 

Given the context, Saint-Gobain is taking all necessary actions to limit the effects of the pandemic on its operating profit and cash as much as possible:

 

- Much greater decrease in capital expenditure than the €200m reduction initially planned for 2020 versus 2019 by deferring all possible projects that were scheduled in the coming months;

- Adaptation of cost structure and postponement of expenses, using local measures where appropriate, in particular unemployment and partial unemployment;

- Ever tighter monitoring of working capital evolution.

 

 

The Group has a very solid financial position and has the necessary cash and financing in place to cope with the consequences of the pandemic. As of December 31, 2019 the Group's cash and cash equivalents stood at €5.0 billion. In addition, the financing sources available to the Group have recently been further reinforced given the current context:

 

- A new syndicated credit line of €2.5 billion, in addition to the confirmed and undrawn back-up credit lines of €4.0 billion;

- Access to the new Pandemic Emergency Purchase Program (PEPP) launched by the European Central Bank on March 18, 2020.

 

At the publication of its 2019 results Saint-Gobain set out its outlook for 2020 subject to the impact of the coronavirus. Given the pandemic, the guidance for 2020 is no longer valid and it is not currently possible to evaluate its impact on the Group's businesses.

 

The Group will provide an update at the publication of its first-quarter 2020 sales on April 23.

 

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€42.6 billion in sales in 2019

Operates in 68 countries

More than 170,000 employees

 

For more information about Saint-Gobain

Visit www.saint-gobain.com

and follow us on Twitter @saintgobain

 

 

 

 

 

Analyst/Investor relations

 

 

Press relations

Vivien Dardel

Floriana Michalowska

Christelle Gannage

 +33 1 47 62 44 29

 +33 1 47 62 35 98

 +33 1 47 62 30 93

Laurence Pernot

Patricia Marie

Susanne Trabitzsch

+33 1 47 62 30 10

+33 1 47 62 51 37

+33 1 47 62 43 25

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGRGDXSGDDGGX
Date   Source Headline
6th Jan 20265:00 pmRNSIntention to delist from the London Stock Exchange
5th Jan 20267:19 amRNSAcquisition
8th Dec 20257:38 amRNSSaint-Gobain cancels 4.2 million shares
1st Dec 20254:58 pmRNSDisposal
30th Oct 20255:54 pmRNS3rd Quarter Results
6th Oct 20257:40 amRNSCapital Markets Day
2nd Oct 20255:10 pmRNSDisposal
1st Oct 20255:08 pmRNSDisposal
26th Sep 20255:14 pmRNSNew plant
8th Sep 20255:12 pmRNSNew construction chemicals organization in Germany
20th Aug 20257:15 amRNSDisposal
31st Jul 20255:51 pmRNSHalf-year Report
29th Jul 20255:10 pmRNSAcquisition
8th Jul 20255:10 pmRNSDisposal
18th Jun 20255:06 pmRNSAcquisition
5th Jun 20256:11 pmRNSNew organization
5th Jun 20255:53 pmRNSAGM Statement
4th Jun 20257:17 amRNSNew plant
20th May 20255:12 pmRNSNew plant
24th Apr 20255:31 pmRNS1st Quarter Results
22nd Apr 20257:00 amRNSSaint-Gobain featured on CDP’s “Climate A List”
26th Mar 20257:00 amRNSBond issue
27th Feb 20255:45 pmRNSAnnual Financial Report
21st Feb 20257:10 amRNSAppointment
10th Feb 20257:12 amRNSAcquisition
4th Feb 20254:54 pmRNSProduction line
16th Jan 20255:41 pmRNSFacility
15th Jan 20255:26 pmRNSAcquisition
3rd Dec 20245:26 pmRNSDecrease in capital
3rd Dec 20247:04 amRNSAcquisition
2nd Dec 20245:10 pmRNSAcquisition
2nd Dec 20247:06 amRNSDisposal
28th Nov 20245:15 pmRNSGovernance
7th Nov 20247:12 amRNSAgreement
29th Oct 20245:55 pmRNS3rd Quarter Results
14th Oct 20245:07 pmRNSAcquisition
8th Oct 20247:05 amRNSAgreement
10th Sep 20245:13 pmRNSDisposal
2nd Sep 20247:06 amRNSDisposal
15th Aug 20246:14 pmRNSAcquisition
31st Jul 20246:07 pmRNSIssue of Debt
26th Jul 20247:00 amRNSHalf-year Report
9th Jul 20247:08 amRNSAcquisition
27th Jun 20247:00 amRNSAcquisition
7th Jun 20247:00 amRNSAGM Statement
3rd Jun 20245:18 pmRNSAcquisition
2nd May 20245:34 pmRNSAgreement
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.